The Expression of AIP-Related Molecules in Elucidation of Cellular Pathways in Pituitary Adenomas

Heaney, 2004, Molecular targets in pituitary tumours, Nat Rev Cancer, 4, 285, 10.1038/nrc1320 Pellegata, 2006, Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans, Proc Natl Acad Sci USA, 103, 15558, 10.1073/pnas.0603877103 Karhu, 2007, Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B, and AIP mutations: an update, Hum Mol Genet, 16, R73, 10.1093/hmg/ddm036 Vierimaa, 2006, Pituitary adenoma predisposition caused by germline mutations in the AIP gene, Science, 312, 1228, 10.1126/science.1126100 Vahteristo, 2007, AIP gene in pituitary adenoma predisposition, Expert Review of Endocrinology & Metabolism, 2, 443, 10.1586/17446651.2.4.443 Leontiou, 2008, The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas, J Clin Endocrinol Metab, 93, 2390, 10.1210/jc.2007-2611 Carver, 1997, Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo, J Biol Chem, 272, 11452, 10.1074/jbc.272.17.11452 Bolger, 2003, Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2, J Biol Chem, 278, 33351, 10.1074/jbc.M303269200 Sumanasekera, 2003, Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2, J Biol Chem, 278, 4467, 10.1074/jbc.M211261200 Yano, 2003, AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins, J Cell Biol, 163, 45, 10.1083/jcb.200305051 Froidevaux, 2006, The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo, EMBO Rep, 7, 1035, 10.1038/sj.embor.7400778 Kang, 2006, Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein, J Biol Chem, 281, 24721, 10.1074/jbc.M603175200 de Oliveira, 2007, Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor, J Biol Chem, 282, 13656, 10.1074/jbc.M610942200 Hankinson, 1995, The aryl hydrocarbon receptor complex, Annu Rev Pharmacol Toxicol, 35, 307, 10.1146/annurev.pa.35.040195.001515 Reyes, 1992, Identification of the ah receptor nuclear translocator protein (arnt) as a component of the DNA binding form of the ah receptor, Science, 256, 1193, 10.1126/science.256.5060.1193 Marlowe, 2005, Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis, J Cell Biochem, 96, 1174, 10.1002/jcb.20656 Barouki, 2007, The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein, FEBS Lett, 581, 3608, 10.1016/j.febslet.2007.03.046 Gu, 2000, The PAS superfamily: sensors of environmental and developmental signals, Annu Rev Pharmacol Toxicol, 40, 519, 10.1146/annurev.pharmtox.40.1.519 Rankin, 2008, The role of hypoxia-inducible factors in tumorigenesis, Cell Death Differ, 15, 678, 10.1038/cdd.2008.21 Kolluri, 1999, p27(Kip1) induction and inhibition of proliferation by the intracellular ah receptor in developing thymus and hepatoma cells, Genes Dev, 13, 1742, 10.1101/gad.13.13.1742 Park, 1999, p27 and rb are on overlapping pathways suppressing tumorigenesis in mice, Proc Natl Acad Sci USA, 96, 6382, 10.1073/pnas.96.11.6382 Donangelo, 2005, Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas, Endocr Pathol, 16, 53, 10.1385/EP:16:1:053 Lidhar, 1999, Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors, J Clin Endocrinol Metab, 84, 3823, 10.1210/jcem.84.10.6066 Georgitsi, 2007, Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia, J Clin Endocrinol Metab, 92, 3321, 10.1210/jc.2006-2843 Meyer, 1999, Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization, Biochemistry, 38, 8907, 10.1021/bi982223w Georgitsi, 2007, Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations, Proc Natl Acad Sci USA, 104, 4101, 10.1073/pnas.0700004104 Raitila, 2007, No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia, Endocr Relat Cancer, 14, 901, 10.1677/ERC-07-0025 Stryke, 2003, BayGenomics: a resource of insertional mutations in mouse embryonic stem cells, Nucleic Acids Res, 31, 278, 10.1093/nar/gkg064 Pollenz, 1999, Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor, Mol Pharmacol, 56, 1127, 10.1124/mol.56.6.1127 Tomita, 2000, Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha, Mol Endocrinol, 14, 1674 Keith, 2001, Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt, Proc Natl Acad Sci USA, 98, 6692, 10.1073/pnas.121494298 Sekine, 2006, Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses, J Biol Chem, 281, 37507, 10.1074/jbc.M606910200 Aitola, 2003, Expression of arnt and Arnt2 mRNA in developing murine tissues, J Histochem Cytochem, 51, 41, 10.1177/002215540305100106 Gunton, 2005, Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes, Cell, 122, 337, 10.1016/j.cell.2005.05.027 Kang, 2006, BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells, J Biol Chem, 281, 14654, 10.1074/jbc.M601613200 Weir, 2007, Characterizing the cancer genome in lung adenocarcinoma, Nature, 450, 893, 10.1038/nature06358 Boikos, 2007, Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis, Hum Mol Genet, 16, R80, 10.1093/hmg/ddm019 Oesch-Bartlomowicz, 2005, Aryl hydrocarbon receptor activation by cAMP vs. dioxin: Divergent signaling pathways, Proc Natl Acad Sci USA, 102, 9218, 10.1073/pnas.0503488102 Jaffrain Rea, 2009, Expression of aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor interacting protein (AIP) in pituitary adenomas: pathological and clinical implications, Endocr Relat Cancer, 16, 1029, 10.1677/ERC-09-0094 Nakata, 2009, G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor, EMBO Rep, 10, 622, 10.1038/embor.2009.35